Logo image of FRST

PRIMIS FINANCIAL CORP (FRST) Stock Fundamental Analysis

USA - NASDAQ:FRST - US74167B1098 - Common Stock

10.64 USD
-0.14 (-1.3%)
Last: 9/22/2025, 4:30:01 PM
10.64 USD
0 (0%)
After Hours: 9/22/2025, 4:30:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FRST. FRST was compared to 392 industry peers in the Banks industry. FRST may be in some trouble as it scores bad on both profitability and health. FRST is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FRST has reported negative net income.
FRST had a negative operating cash flow in the past year.
In multiple years FRST reported negative net income over the last 5 years.
In the past 5 years FRST always reported a positive cash flow from operatings.
FRST Yearly Net Income VS EBIT VS OCF VS FCFFRST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

1.2 Ratios

With a Return On Assets value of 0.08%, FRST is not doing good in the industry: 88.27% of the companies in the same industry are doing better.
With a Return On Equity value of 0.79%, FRST is not doing good in the industry: 88.27% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.08%
ROE 0.79%
ROIC N/A
ROA(3y)-0.05%
ROA(5y)0.3%
ROE(3y)-0.73%
ROE(5y)2.27%
ROIC(3y)N/A
ROIC(5y)N/A
FRST Yearly ROA, ROE, ROICFRST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5

1.3 Margins

Looking at the Profit Margin, with a value of 1.67%, FRST is doing worse than 88.52% of the companies in the same industry.
FRST does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 1.67%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRST Yearly Profit, Operating, Gross MarginsFRST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

FRST does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FRST remains at a similar level compared to 1 year ago.
The number of shares outstanding for FRST has been increased compared to 5 years ago.
FRST has a worse debt/assets ratio than last year.
FRST Yearly Shares OutstandingFRST Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
FRST Yearly Total Debt VS Total AssetsFRST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

A Debt/Equity ratio of 0.31 indicates that FRST is not too dependend on debt financing.
FRST has a worse Debt to Equity ratio (0.31) than 68.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC27.55%
FRST Yearly LT Debt VS Equity VS FCFFRST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
FRST Yearly Current Assets VS Current LiabilitesFRST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

6

3. Growth

3.1 Past

The earnings per share for FRST have decreased strongly by -125.60% in the last year.
FRST shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -63.19% yearly.
Looking at the last year, FRST shows a very strong growth in Revenue. The Revenue has grown by 26.50%.
Measured over the past years, FRST shows a quite strong growth in Revenue. The Revenue has been growing by 9.18% on average per year.
EPS 1Y (TTM)-125.6%
EPS 3Y-80.05%
EPS 5Y-63.19%
EPS Q2Q%-65.62%
Revenue 1Y (TTM)26.5%
Revenue growth 3Y11.85%
Revenue growth 5Y9.18%
Sales Q2Q%-7.74%

3.2 Future

Based on estimates for the next years, FRST will show a very strong growth in Earnings Per Share. The EPS will grow by 1156.97% on average per year.
FRST is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.17% yearly.
EPS Next Y3000.8%
EPS Next 2Y1156.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.02%
Revenue Next 2Y9.17%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
FRST Yearly Revenue VS EstimatesFRST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
FRST Yearly EPS VS EstimatesFRST Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

FRST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 6.73, which indicates a rather cheap valuation of FRST.
91.58% of the companies in the same industry are more expensive than FRST, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, FRST is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.73
FRST Price Earnings VS Forward Price EarningsFRST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRST Per share dataFRST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FRST's earnings are expected to grow with 1156.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1156.97%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.59%, FRST has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.47, FRST pays a bit more dividend than its industry peers.
FRST's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.59%

5.2 History

The dividend of FRST has a limited annual growth rate of 2.16%.
FRST has paid a dividend for at least 10 years, which is a reliable track record.
FRST has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.16%
Div Incr Years0
Div Non Decr Years12
FRST Yearly Dividends per shareFRST Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

333.45% of the earnings are spent on dividend by FRST. This is not a sustainable payout ratio.
FRST's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP333.45%
EPS Next 2Y1156.97%
EPS Next 3YN/A
FRST Yearly Income VS Free CF VS DividendFRST Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
FRST Dividend Payout.FRST Dividend Payout, showing the Payout Ratio.FRST Dividend Payout.PayoutRetained Earnings

PRIMIS FINANCIAL CORP

NASDAQ:FRST (9/22/2025, 4:30:01 PM)

After market: 10.64 0 (0%)

10.64

-0.14 (-1.3%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners75.52%
Inst Owner Change-1.48%
Ins Owners3.14%
Ins Owner Change0.83%
Market Cap262.17M
Analysts87.5
Price Target13.9 (30.64%)
Short Float %0.67%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield 3.59%
Yearly Dividend0.4
Dividend Growth(5Y)2.16%
DP333.45%
Div Incr Years0
Div Non Decr Years12
Ex-Date08-08 2025-08-08 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-47.47%
Min EPS beat(2)-49.84%
Max EPS beat(2)-45.1%
EPS beat(4)0
Avg EPS beat(4)-214%
Min EPS beat(4)-679.32%
Max EPS beat(4)-45.1%
EPS beat(8)2
Avg EPS beat(8)-100.38%
EPS beat(12)2
Avg EPS beat(12)-85.19%
EPS beat(16)4
Avg EPS beat(16)-65.58%
Revenue beat(2)0
Avg Revenue beat(2)-7.72%
Min Revenue beat(2)-11.6%
Max Revenue beat(2)-3.85%
Revenue beat(4)1
Avg Revenue beat(4)-5.34%
Min Revenue beat(4)-11.6%
Max Revenue beat(4)3.43%
Revenue beat(8)3
Avg Revenue beat(8)-1.98%
Revenue beat(12)5
Avg Revenue beat(12)2.69%
Revenue beat(16)9
Avg Revenue beat(16)4.77%
PT rev (1m)1.87%
PT rev (3m)10.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.92%
EPS NY rev (1m)0%
EPS NY rev (3m)-59.63%
Revenue NQ rev (1m)-15.78%
Revenue NQ rev (3m)-6.72%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.73
P/S 1.47
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)1.58
Fwd EY14.85%
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.49
OCFYN/A
SpS7.22
BVpS15.28
TBVpS11.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.67%
GM N/A
FCFM N/A
ROA(3y)-0.05%
ROA(5y)0.3%
ROE(3y)-0.73%
ROE(5y)2.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC27.55%
ROIC/WACCN/A
Cap/Depr(3y)16.04%
Cap/Depr(5y)22.45%
Cap/Sales(3y)0.98%
Cap/Sales(5y)1.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-125.6%
EPS 3Y-80.05%
EPS 5Y-63.19%
EPS Q2Q%-65.62%
EPS Next Y3000.8%
EPS Next 2Y1156.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.5%
Revenue growth 3Y11.85%
Revenue growth 5Y9.18%
Sales Q2Q%-7.74%
Revenue Next Year5.02%
Revenue Next 2Y9.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.63%
FCF growth 3Y-9.65%
FCF growth 5Y-12.46%
OCF growth 1Y-7.96%
OCF growth 3Y-10.59%
OCF growth 5Y-11.88%